Abstract
Jonas Salk died on 23 June 1995, and so is prevented from writing about the development of what he called “non-infectious polio vaccine”. My credentials to undertake the task are not perfect. I never worked for Jonas directly and by the time I reached Toronto to take up a Research Fellowship in Virus Diseases under the directions of Dr. Andrew Rhodes at the Hospital for Sick Children in September 1954, the Francis Trial of injectable polio vaccine (IPV) was already in progress.
Toronto, at the time of working for Andrew Rhodes, was an excellent place to observe the development of both IPV and oral polio vaccine (OPV). Rhodes in 1947 had set up a polio research unit at the Connaught Laboratories associated with the School of Hygiene of the University of Toronto. This unit was to play a decisive role in the development of IPV.
Deceased
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kolmer JA. Vaccination against acute anterior poliomyelitis. Am J Public Health 1936;26:125–35
Brodie M, Park WH. Active immunisation against poliomyelitis. Am J Public Health 1936;26:119–25
Sabin AB, Olitsky PK. Cultivation of poliomyelitis virus in human embryonic nervous tissue. Proc Soc Exp Biol Med 1936;31:357–9
Burnet FM, McNamara J. Immunological differences between strains of poliomyelitis virus. Br J Ex Path 1931;12:57–61
Enders JF, Weller TH, Robbins FC. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 1949;109:234–45
Bodian D. Morgan IM, Howe HA. Differentiation of types of poliomyelitis viruses; the grouping of fourteen strains into three basic immunologic types. Am J Hyg 1949;49:234–45
Salk J. Poliomyelitis Vaccine in the fall of 1955. Am J Public Health 1956;46:1–14
Van Riper HE. Progress in the control of paralytic poliomyelitis through vaccination. Can J Public Health 1955;46:427–48
Morgan JF, Morton HJ, Parker RC. Nutrition of animal cells in tissue culture. 1. Initial studies on a synthetic medium. Proc Soc Exp Biol and Med 1950;73:1–8
Maitland HB, Maitland MC. Cultivation of vaccinia virus without tissue culture. Lancet 1928;2:596–7
Wood W, Shimada FT. Isolation of strains of Virus B from tissue cultures of cynomolgus and rhesus kidney. Can J Publ Hlth 1954;45:509–18
Farrell LN, Wood W, Franklin RE, Shimada F, Macmorine H, Rhodes AJ. Cultivation of poliomyelitis virus in tissue culture: VI methods for quantity production of poliomyelitis viruses in cultures of monkey kidney. Can J Public Health 1953;44:273–80
Francis TM Jr, Napier JA, Voight RB et al. Evaluation of the 1954 field trial of poliomyelitis vaccine. Final Report Ann Arbor University of Michigan 1957
Fantes KH. Concentrations and partial purification of poliomyelitis viruses. J Hygiene 1962;60:123–33
LeBouvier GL. The D to C change in poliovirus particles. Br J Exper Path 1959;40:605–20
Beale AJ. The D-antigen content in polio vaccine as a measure of potency. Lancet 1961;2:1166–8
Hull R, Minner JR, Mascoli GC. New agents recovered from tissue culture of monkey kidney cells: III Recovery of additional agents both from cultures of monkey kidney tissues and directly from tissues and excreta. Am J Hyg 1959;68:31–44
Sweet DH, Hilleman MR. The vacoulating virus, SV40. Proc Soc Exp Biol Med 1960;105:420–7
Van Wesel AL4, van Steenis G, van der Marel P, Osterhouse ADM. Inactivated poliovirus vaccine: current production methods and new developments. Rev Infect Dis 1984; 6 (suppl 2):335–40
Montagnon B, Fanget B, Vincent-Falguet JC. Industrial scale production of inactivated poliovirus vaccine prepared by culture of Vero cells and microcarriers. Rev Infect Dis 1984;6S:341–4
Beale AJ, Mason PJ, The measurement of D-antigen in poliovirus preparations. J Hyg 1962;60 :113–21
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Beale, A.J. (2011). The Development of IPV. In: Plotkin, S. (eds) History of Vaccine Development. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1339-5_20
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1339-5_20
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1338-8
Online ISBN: 978-1-4419-1339-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)